Shandong Xinhua Pharmaceutical Company Limited (000756.SZ)
CNY 15.85
(0.38%)
CNY 15.85
(0.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 8 Billion | 7.5 Billion | 6.56 Billion | 6 Billion | 5.6 Billion | 5.2 Billion |
| Cost of Revenue | 5.8 Billion | 5.46 Billion | 4.78 Billion | 4.19 Billion | 3.73 Billion | 3.64 Billion |
| Gross Profit | 2.2 Billion | 2.03 Billion | 1.77 Billion | 1.81 Billion | 1.87 Billion | 1.55 Billion |
| Operating Expenses | 1.85 Billion | 1.49 Billion | 1.27 Billion | 1.27 Billion | 1.36 Billion | 1.14 Billion |
| Selling, General and Administrative Expenses | 1.21 Billion | 814.85 Million | 688.88 Million | 736.91 Million | 893.85 Million | 740.71 Million |
| Research and Development Expenses | 419.23 Million | 345.65 Million | 341.36 Million | 298.34 Million | 235.4 Million | 186.97 Million |
| Other Expenses | - | 333.39 Million | 244.42 Million | 236.46 Million | 235.49 Million | -12.23 Million |
| Cost and Expenses | 7.49 Billion | 6.95 Billion | 6.06 Billion | 5.46 Billion | 5.09 Billion | 4.79 Billion |
| Operating Income | 534.58 Million | 476.7 Million | 425.59 Million | 422.48 Million | 387.43 Million | 337.31 Million |
| Interest Expense | 44.07 Million | 49.7 Million | 53.1 Million | 59.75 Million | 55.31 Million | 54.55 Million |
| Income Tax Expense | 26.57 Million | 45.45 Million | 59.15 Million | 64.52 Million | 58.27 Million | 50.79 Million |
| Earnings before Tax | 532.68 Million | 471.77 Million | 421.23 Million | 411.63 Million | 381.39 Million | 325.07 Million |
| Net Income | 496.51 Million | 411.06 Million | 348.54 Million | 324.85 Million | 299.96 Million | 250.83 Million |
| Earnings Per Share Basic | 0.74 | 0.62 | 0.56 | 0.52 | 0.48 | 0.40 |
| Earnings Per Share Diluted | 0.72 | 0.61 | 0.56 | 0.52 | 0.48 | 0.40 |
| Weighted Average Shares Outstanding | 670.96 Million | 663 Million | 622.4 Million | 621.85 Million | 621.85 Million | 621.85 Million |
| Weighted Average Shares Outstanding (Diluted) | 689.6 Million | 673.87 Million | 622.4 Million | 621.85 Million | 621.85 Million | 622.71 Million |
| Gross Margin | 0.28 | 0.27 | 0.27 | 0.30 | 0.33 | 0.30 |
| EBIT Margin | 0.14 | 0.14 | 0.14 | 0.15 | 0.15 | 0.14 |
| Profit Margin | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| EBITDA | 1.09 Billion | 1.01 Billion | 920.88 Million | 865.31 Million | 781.33 Million | 697.55 Million |
| Earnings Before Tax Margin | 0.07 | 0.06 | 0.06 | 0.07 | 0.07 | 0.06 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 2 Billion | 2.23 Billion | 2.47 Billion | 8 Billion | 1.58 Billion | 1.82 Billion |
| Cost of Revenue | 1.6 Billion | 1.77 Billion | 1.79 Billion | 5.8 Billion | 1.12 Billion | 1.32 Billion |
| Gross Profit | 397.7 Million | 463.29 Million | 678.96 Million | 2.2 Billion | 465.57 Million | 498.9 Million |
| Operating Expenses | 297.37 Million | 348.69 Million | 507.55 Million | 1.69 Billion | 379.06 Million | 386.76 Million |
| Selling, General and Administrative Expenses | 384.01 Million | 199.18 Million | 369.9 Million | - | 276.16 Million | 429.32 Million |
| Research and Development Expenses | 83.56 Million | 101.19 Million | 141.9 Million | - | 77.95 Million | 105.75 Million |
| Other Expenses | -170.2 Million | -48.31 Million | -1.78 Million | -63.41 Million | -24.94 Million | 1.61 Million |
| Cost and Expenses | 1.9 Billion | 2.12 Billion | 2.3 Billion | 7.49 Billion | 1.5 Billion | 1.71 Billion |
| Operating Income | 90.7 Million | 114.6 Million | 170.55 Million | 512.41 Million | 86.5 Million | 112.91 Million |
| Interest Expense | 10.24 Million | 8.65 Million | 9.21 Million | 41.14 Million | 9.43 Million | 10.22 Million |
| Income Tax Expense | 6.87 Million | 7.09 Million | 23.5 Million | 26.57 Million | -19.6 Million | -10.07 Million |
| Earnings before Tax | 89.55 Million | 134.44 Million | 168.77 Million | 531.26 Million | 86.31 Million | 114.53 Million |
| Net Income | 78.67 Million | 123.52 Million | 141.87 Million | 496.51 Million | 104.54 Million | 122.16 Million |
| Earnings Per Share Basic | 0.12 | 0.18 | 0.21 | - | 0.16 | 0.18 |
| Earnings Per Share Diluted | 0.12 | 0.17 | 0.21 | - | 0.16 | 0.18 |
| Weighted Average Shares Outstanding | 682.4 Million | 682.4 Million | 675.61 Million | 670.96 Million | 674.68 Million | 674.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 682.4 Million | 710.08 Million | 675.61 Million | 689.6 Million | 674.68 Million | 674.68 Million |
| Gross Margin | 0.20 | 0.21 | 0.27 | 0.28 | 0.29 | 0.27 |
| EBIT Margin | 0.05 | 0.11 | 0.07 | - | 0.14 | 0.06 |
| Profit Margin | 0.04 | 0.06 | 0.06 | 0.06 | 0.07 | 0.07 |
| EBITDA | 99.8 Million | 248.47 Million | 177.07 Million | - | 217.85 Million | 117.35 Million |
| Earnings Before Tax Margin | 0.05 | 0.05 | 0.07 | 0.06 | 0.05 | 0.06 |
0QPR
LUXIND
WBT
M&MFIN
1490
SACHEMT